Lupus (SLE) trials in Guatemala

2 of 3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  Where

  Guatemala City

  Age

  12 years to 100 years

  People

  550 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06133972 · EU 2023-505929-14-00
• Phase 3Taking people
  Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  Where

  Guatemala City, Quetzaltenango

  Age

  18 years to 100 years

  People

  348 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06711887 · EU 2024-515280-60-00